Previously-untreated patients with hepatocellular carcinoma (HCC), a common form of liver cancer, will have an immunotherapy-based treatment option after NICE gave the nod to NHS funding of Roche ...

If you are overweight or have obesity, losing weight is one of the best ways ... the risk factors for liver cancer and what screenings might be right for you. Successful treatment is more likely ...

Here is the most-viewed liver ... Cancer Research Program at Vanderbilt University Medical Center, the results of EMERALD-1 “have the potential to establish a new standard of care for the ...

performed the best out of various dosing regimens in patients with advanced hepatocellular carcinoma (HCC), the most common type of liver cancer. The trial bucks the prevailing trend of ...

"My answer wasn't the best," she ... but that pesky liver cancer was not going away. It had shrunk, but it would need more than chemotherapy and the immunotherapy medications Roper will continue ...

Liver cancer is a disease with a poor prognosis. Despite multiple therapeutic options, including the recent emergence of immunotherapy as a first-line systemic treatment, the outcomes remain poor.

Biomarker staging of liver fibrosis in hepatitis C was cost effective, but so was initiating treatment without testing.

Biomarkers in Blood to Predict Liver Cancer May 1, 2024 — Early detection has the potential to transform treatment and outcomes in cancer care, especially for cancers like liver cancer ...

An abstract outlining final data from a previous Phase 2 trial featuring casdozo in combination with another treatment regimen ... for targeting IL-27 in liver cancer and now translation to ...

Metastatic bowel cancer is cancer that has spread from the back passage (rectum) and large intestines (colon) to other parts of the body, such as the liver. Sometimes cancer has spread when it is ...